Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
Aligos Therapeutics, Inc.
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Aligos Therapeutics, Inc.
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
Aligos Therapeutics, Inc.
SIC 2836 · Biological Products, (No Diagnostic Substances)
Notes
Support
about
terms
$
ALGS
Aligos Therapeutics, Inc.
CIK:
0001799448
|
SEC Filings
ARTICLES AND BYLAWS
EX-3.1
d98914dex31.htm
2025-06-26T00:00:00Z
EX-3.1
d882619dex31.htm
2024-08-19T00:00:00Z
EX-3.1
d129014dex31.htm
2024-06-28T00:00:00Z
EX-3.2
d46540dex32.htm
2020-10-20T00:00:00Z
EX-3.1
d46540dex31.htm
2020-10-20T00:00:00Z
EX-3.5
d31402dex35.htm
2020-10-09T00:00:00Z
EX-3.2
d31402dex32.htm
2020-10-09T00:00:00Z
EX-3.3
d31402dex33.htm
2020-10-09T00:00:00Z
EX-3.1
d31402dex31.htm
2020-09-25T00:00:00Z
EX-3.4
d31402dex34.htm
2020-09-25T00:00:00Z